Clinical trial
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
NCT01425463 is registered in ClinicalTrials.gov with Sanol GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized and Multi-center Trial to Investigate Efficacy and Safety in Subjects With Iron Deficiency Anemia for Ferrous (II) Glycine Sulphate Complex Versus Polyferose Capsules Therapy
- Lead sponsor
- Sanol GmbH
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- November 30, 2013
- Enrollment
- 256 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
iron deficiency anemia